|
Pharma packaging materials and technical pharma-grade solutions
|
|
December 04 , 2025
|
|
|
Company Foundation and Vision
Established in 2002, Longrun Packaging is a highly respected and specialised manufacturer of pharmaceutical packaging materials and technical pharma-grade solutions. For over 20 years, the company has operated with a singular, clear vision: to deliver packaging that consistently upholds the highest standards of quality, patient safety, and international regulatory requirements in one of the world's most demanding markets.
Operational Excellence and Capacity
Longrun operates a robust, compliance-driven infrastructure dedicated to precision and quality control:
• Production Facility: Spanning 24,000 square metres of advanced production space.
• Quality Control: Supported by a dedicated 400-square-metre laboratory equipped with state-of-the-art testing and analytical systems.
• Annual Capacity: A leading capacity of nearly 10,000 metric tons of pharmaceutical-grade packaging materials.
• Process Design: The entire production ecosystem is designed to ensure complete traceability, minimal contamination risk, and absolute product consistency.
Global Compliance and Quality Benchmarks
The company's core competitive advantage lies in its comprehensive adherence to stringent global standards, ensuring its position as a trusted supplier worldwide.
Compliance
Area
|
Standard
/ Certification
|
Focus
|
Quality
Management
|
ISO
9001
|
General
quality management systems.
|
Pharma
Packaging Quality
|
ISO
15378
|
Primary
pharmaceutical packaging materials (incorporates GMP principles).
|
Manufacturing
Standards
|
GMP/GMT
Regulations
|
Adherence
to Good Manufacturing/Material Handling Practices.
|
Environmental
Management
|
ISO
14001
|
Environmental
impact and sustainability.
|
Health
& Safety
|
ISO
45001
|
Occupational
health and safety practices.
|
International
Benchmarks
|
Japan's
Standards,
US
Regulatory Expectations,
Chinese
Domestic Requirements
|
Demonstrates
ability to meet some of the world's strictest quality and
regulatory demands.
|
Market Footprint and Strategy
Longrun is a leading force in the global pharma supply chain, with a strategic focus on markets where compliance and quality are prioritised over low pricing.
• Manufacturing Base: Primarily located in China.
• Export Markets: Active and reliable long-term partnerships across African nations, Pakistan, and South American countries.
• Market Stance (India): The company currently avoids entry into the Indian market due to extremely low price expectations, which it believes can compromise long-term product quality and business sustainability.
Strategic Outlook
Acknowledging the current global slowdown and challenging industry environment, Longrun maintains a focused strategy centred on continuous improvement:
• Core Focus: Reinforcing the importance of strict compliance, operational efficiency, and technological advancement to maintain a competitive edge.
• Future Investment: Dedicated investment in research, automation, and sustainable production methods.
Longrun Packaging stands committed to being a reliable, world-class partner, ensuring the safe and secure delivery of medicines to patients globally.
|
|
|
|
|
|
|
|
TOPICS
|
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...
|
|
|
|
|